Literature DB >> 24311357

Role of neuronal nicotinic acetylcholine receptors (nAChRs) on learning and memory in zebrafish.

Daniela Braida1, Luisa Ponzoni, Roberta Martucci, Fabio Sparatore, Cecilia Gotti, Mariaelvina Sala.   

Abstract

RATIONALE: Neuronal nicotinic acetylcholine receptors (nAChRs) play a modulatory role in cognition, and zebrafish provide a preclinical model to study learning and memory.
OBJECTIVES: We investigated the effect of nicotine (NIC) and some new cytisine-derived partial agonists (CC4 and CC26) on spatial memory in zebrafish using a rapid assay on T-maze task. The role of α4/α6β2 and the α7 nAChRs in NIC-induced memory enhancement was evaluated using selective nAChR antagonists.
RESULTS: Low and high doses of NIC, cytisine (CYT), CC4 and CC26 respectively improved and worsened the mean running time, showing an inverted U dose-response function. The effective dose (ED50) (×10⁻⁵ mg/kg) was 0.4 for CC4, 4.5 for CYT, 140 for NIC and 200 for CC26. NIC-induced cognitive enhancement was reduced by the selective nAChR subtype antagonists: methyllycaconitine (MLA) for α7, α-conotoxin (MII) for α6β2, dihydro-β-erythroidine (DhβE) for α4β2, the nonselective antagonist mecamylamine (MEC) and the muscarinic antagonist scopolamine (SCOP), with DhβE being more active than MLA or MII. All the partial agonists blocked the cognitive enhancement. The improvement with the maximal active dose of each partial agonist was blocked by low doses of DhβE (0.001 mg/kg) and MII (0.01 mg/kg). MLA reduced the effects of CC26 and CC4 at doses of 0.01 and 1 mg/kg, respectively, but did not antagonize CYT-induced memory improvement at any of the tested dose. No change in swimming activity was observed.
CONCLUSIONS: Our findings demonstrate that zebrafish make a useful model for the rapid screening of the effect of new α4β2 nAChR compounds on spatial memory.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24311357     DOI: 10.1007/s00213-013-3340-1

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  58 in total

Review 1.  Zebrafish: a new model for human disease.

Authors:  L I Zon
Journal:  Genome Res       Date:  1999-02       Impact factor: 9.043

2.  Immediate and sustained improvements in working memory after selective stimulation of α7 nicotinic acetylcholine receptors.

Authors:  Stacy A Castner; Gennady N Smagin; Timothy M Piser; Yi Wang; Jeffrey S Smith; Edward P Christian; Ladislav Mrzljak; Graham V Williams
Journal:  Biol Psychiatry       Date:  2010-10-20       Impact factor: 13.382

3.  Visual discrimination learning in zebrafish (Danio rerio).

Authors:  Ruth M Colwill; Maria P Raymond; Lisa Ferreira; Holly Escudero
Journal:  Behav Processes       Date:  2005-08-31       Impact factor: 1.777

4.  Preclinical pharmacology of the alpha4beta2 nAChR partial agonist varenicline related to effects on reward, mood and cognition.

Authors:  Hans Rollema; Mihály Hajós; Patricia A Seymour; Rouba Kozak; Mark J Majchrzak; Victor Guanowsky; Weldon E Horner; Doug S Chapin; William E Hoffmann; David E Johnson; Stafford McLean; Jody Freeman; Kathryn E Williams
Journal:  Biochem Pharmacol       Date:  2009-06-06       Impact factor: 5.858

5.  Enhancement of attentional performance by selective stimulation of alpha4beta2(*) nAChRs: underlying cholinergic mechanisms.

Authors:  William M Howe; Jinzhao Ji; Vinay Parikh; Sarah Williams; Elisabeth Mocaër; Caryn Trocmé-Thibierge; Martin Sarter
Journal:  Neuropsychopharmacology       Date:  2010-02-10       Impact factor: 7.853

Review 6.  Targeting the nicotinic alpha7 acetylcholine receptor to enhance cognition in disease.

Authors:  Tanya L Wallace; Richard H P Porter
Journal:  Biochem Pharmacol       Date:  2011-07-02       Impact factor: 5.858

7.  Improvement in performance of a delayed matching-to-sample task by monkeys following ABT-418: a novel cholinergic channel activator for memory enhancement.

Authors:  J J Buccafusco; W J Jackson; A V Terry; K C Marsh; M W Decker; S P Arneric
Journal:  Psychopharmacology (Berl)       Date:  1995-08       Impact factor: 4.530

Review 8.  Nicotinic acetylcholine involvement in cognitive function in animals.

Authors:  E D Levin; B B Simon
Journal:  Psychopharmacology (Berl)       Date:  1998-08       Impact factor: 4.530

9.  Broad-spectrum efficacy across cognitive domains by alpha7 nicotinic acetylcholine receptor agonism correlates with activation of ERK1/2 and CREB phosphorylation pathways.

Authors:  Robert S Bitner; William H Bunnelle; David J Anderson; Clark A Briggs; Jerry Buccafusco; Peter Curzon; Michael W Decker; Jennifer M Frost; Jens Halvard Gronlien; Earl Gubbins; Jinhe Li; John Malysz; Stella Markosyan; Kennan Marsh; Michael D Meyer; Arthur L Nikkel; Richard J Radek; Holly M Robb; Daniel Timmermann; James P Sullivan; Murali Gopalakrishnan
Journal:  J Neurosci       Date:  2007-09-26       Impact factor: 6.167

10.  Cognitive aging in zebrafish.

Authors:  Lili Yu; Valter Tucci; Shuji Kishi; Irina V Zhdanova
Journal:  PLoS One       Date:  2006-12-20       Impact factor: 3.240

View more
  15 in total

1.  The cytisine derivatives, CC4 and CC26, reduce nicotine-induced conditioned place preference in zebrafish by acting on heteromeric neuronal nicotinic acetylcholine receptors.

Authors:  Luisa Ponzoni; Daniela Braida; Luca Pucci; Donzelli Andrea; Francesca Fasoli; Irene Manfredi; Roger L Papke; Clare Stokes; Giuseppe Cannazza; Francesco Clementi; Cecilia Gotti; Mariaelvina Sala
Journal:  Psychopharmacology (Berl)       Date:  2014-05-27       Impact factor: 4.530

2.  Single dose varenicline may trigger epileptic activity.

Authors:  Haydar Ali Erken; Gülten Erken; Hasan Simşek; Oğuzhan Korkut; Emine Rabia Koç; Ozlem Yavuz; Osman Genç
Journal:  Neurol Sci       Date:  2014-06-07       Impact factor: 3.307

Review 3.  Pharmacological analyses of learning and memory in zebrafish (Danio rerio).

Authors:  Jordan M Bailey; Anthony N Oliveri; Edward D Levin
Journal:  Pharmacol Biochem Behav       Date:  2015-03-17       Impact factor: 3.533

4.  α7 nicotinic ACh receptor-deficient mice exhibit sustained attention impairments that are reversed by β2 nicotinic ACh receptor activation.

Authors:  Benjamin Kolisnyk; Mohammed A Al-Onaizi; Vania F Prado; Marco A M Prado
Journal:  Br J Pharmacol       Date:  2015-09-22       Impact factor: 8.739

5.  Conservation of mechanisms regulating emotional-like responses on spontaneous nicotine withdrawal in zebrafish and mammals.

Authors:  Luisa Ponzoni; Gloria Melzi; Laura Marabini; Andrea Martini; Giulia Petrillo; Muy-Teck Teh; Jose V Torres-Perez; Stefano Morara; Cecilia Gotti; Daniela Braida; Caroline H Brennan; Mariaelvina Sala
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2021-04-24       Impact factor: 5.067

6.  An ancient conserved role for prion protein in learning and memory.

Authors:  Patricia L A Leighton; Nathan J Nadolski; Adam Morrill; Trevor J Hamilton; W Ted Allison
Journal:  Biol Open       Date:  2018-01-22       Impact factor: 2.422

7.  Commentary: Establishing zebrafish as a model to study the anxiolytic effects of scopolamine.

Authors:  Murilo S de Abreu; Ashton J Friend; Tamara G Amstislavskaya; Allan V Kalueff
Journal:  Front Pharmacol       Date:  2018-04-03       Impact factor: 5.810

8.  Rosmarinus officinalis Essential Oil Improves Scopolamine-Induced Neurobehavioral Changes via Restoration of Cholinergic Function and Brain Antioxidant Status in Zebrafish (Danio rerio).

Authors:  Luminita Capatina; Razvan Stefan Boiangiu; Gabriela Dumitru; Edoardo Marco Napoli; Giuseppe Ruberto; Lucian Hritcu; Elena Todirascu-Ciornea
Journal:  Antioxidants (Basel)       Date:  2020-01-10

9.  Reversal of reserpine-induced depression and cognitive disorder in zebrafish by sertraline and Traditional Chinese Medicine (TCM).

Authors:  Shuhui Zhang; Xiaodong Liu; Mingzhu Sun; Qiuping Zhang; Teng Li; Xiang Li; Jia Xu; Xin Zhao; Dongyan Chen; Xizeng Feng
Journal:  Behav Brain Funct       Date:  2018-06-14       Impact factor: 3.759

10.  Establishing zebrafish as a model to study the anxiolytic effects of scopolamine.

Authors:  Trevor J Hamilton; Adam Morrill; Kayla Lucas; Joshua Gallup; Megan Harris; Meghan Healey; Taylor Pitman; Melike Schalomon; Shannon Digweed; Martin Tresguerres
Journal:  Sci Rep       Date:  2017-11-08       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.